Li Ju Yeh
Directeur/Bestuurslid bij DELTA ASIA INTERNATIONAL CORPORATION
Profiel
Li Ju Yeh is an Independent Director at Delta Asia International Corp.
and Tricorntech Corp.
She previously worked as Deputy Spokesman and Head of Finance & Accounting at TWi Pharmaceuticals, Inc. and as Assistant Deputy GM and Head of Finance & Accounting at TWi Biotechnology, Inc. Ms. Yeh is a graduate of National Sun Yat-Sen University.
Actieve functies van Li Ju Yeh
| Bedrijven | Functie | Begin |
|---|---|---|
| DELTA ASIA INTERNATIONAL CORPORATION | Directeur/Bestuurslid | 12-11-2019 |
| TRICORNTECH TAIWAN CORPORATION | Directeur/Bestuurslid | - |
Eerdere bekende functies van Li Ju Yeh
| Bedrijven | Functie | Einde |
|---|---|---|
| TWI BIOTECHNOLOGY, INC. | Financieel Directeur/CFO | 01-09-2019 |
| TWI PHARMACEUTICALS INC | Financieel Directeur/CFO | - |
Opleiding van Li Ju Yeh
| National Sun Yat-Sen University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| TWI BIOTECHNOLOGY, INC. | Health Technology |
| DELTA ASIA INTERNATIONAL CORPORATION | Health Technology |
| TRICORNTECH TAIWAN CORPORATION | Electronic Technology |
| Bedrijven in privébezit | 1 |
|---|---|
TWi Pharmaceuticals, Inc.
 TWi Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TWi Pharmaceuticals, Inc. operates as a technology-based special pharmaceutical company. The firm engages in the development and commercialization of high barrier generics drugs. Its products include donepezil hydrochloride tablets, megestrol acetate oral suspension, hydroquinone cream, guanfacine extended-release tablets and nifedipine extended-release tablets. The company was founded by Chih Ming Chen on December 1, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
